Advertisement

Reactions Weekly

, Volume 1695, Issue 1, pp 206–206 | Cite as

Ibrutinib

Vasculitic rash and foot pain: case report
Case report
  • 16 Downloads

Reference

  1. Treon SP, et al. Ibrutinib is highly active as first line therapy in symptomatic waldenstrom's macroglobulinemia. Blood 130 (Suppl. 1): Dec 2017 [abstract] -USAGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations